CI vs IMA
Cigna Corp (CI) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. IMA currently screens at market cap $64.7M.
Not investment advice. Open the CI and IMA stock pages for the full models.
Not investment advice.